However, recent studies, particularly the head-to-head trials, suggest that tirzepatide (Zepbound) generally leads to greater average weight loss than semaglutide (Wegovy)
However, this is a speculative estimate based on severe injuries in other pharmaceutical litigations
This study aims to explore this gap by utilizing data from the large community-based database, TriNetX, to investigate the association between GLP-1 RA use and the risk of psychiatric diseases, including major depression, anxiety and suicidal behaviour in patients with obesity
When Hims & Hers Health Inc
The goal is to help you set realistic expectations, understand what youre experiencing, and have clearer conversations about next steps in your care